Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1989 1
1992 1
1993 1
1995 1
1996 3
1997 4
1998 6
1999 7
2000 2
2001 6
2002 5
2003 9
2004 4
2005 2
2006 3
2007 3
2008 8
2009 4
2010 3
2011 12
2012 3
2013 5
2014 3
2015 2
2016 5
2017 4
2018 7
2019 4
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
Why Cancer?
Haycox A. Haycox A. Pharmacoeconomics. 2016 Jul;34(7):625-7. doi: 10.1007/s40273-016-0413-0. Pharmacoeconomics. 2016. PMID: 27194312 Free PMC article. No abstract available.
A review of telemedicine cost-effectiveness studies.
Mair FS, Haycox A, May C, Williams T. Mair FS, et al. Among authors: haycox a. J Telemed Telecare. 2000;6 Suppl 1:S38-40. doi: 10.1258/1357633001934096. J Telemed Telecare. 2000. PMID: 10793967 Review.
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation.
Vella Bonanno P, Ermisch M, Godman B, Martin AP, Van Den Bergh J, Bezmelnitsyna L, Bucsics A, Arickx F, Bybau A, Bochenek T, van de Casteele M, Diogene E, Eriksson I, Fürst J, Gad M, Greičiūtė-Kuprijanov I, van der Graaff M, Gulbinovic J, Jones J, Joppi R, Kalaba M, Laius O, Langner I, Mardare I, Markovic-Pekovic V, Magnusson E, Melien O, Meshkov DO, Petrova GI, Selke G, Sermet C, Simoens S, Schuurman A, Ramos R, Rodrigues J, Zara C, Zebedin-Brandl E, Haycox A. Vella Bonanno P, et al. Among authors: haycox a. Front Pharmacol. 2017 Aug 23;8:497. doi: 10.3389/fphar.2017.00497. eCollection 2017. Front Pharmacol. 2017. PMID: 28878667 Free PMC article. Review.
Personalizing health care: feasibility and future implications.
Godman B, Finlayson AE, Cheema PK, Zebedin-Brandl E, Gutiérrez-Ibarluzea I, Jones J, Malmström RE, Asola E, Baumgärtel C, Bennie M, Bishop I, Bucsics A, Campbell S, Diogene E, Ferrario A, Fürst J, Garuoliene K, Gomes M, Harris K, Haycox A, Herholz H, Hviding K, Jan S, Kalaba M, Kvalheim C, Laius O, Lööv SA, Malinowska K, Martin A, McCullagh L, Nilsson F, Paterson K, Schwabe U, Selke G, Sermet C, Simoens S, Tomek D, Vlahovic-Palcevski V, Voncina L, Wladysiuk M, van Woerkom M, Wong-Rieger D, Zara C, Ali R, Gustafsson LL. Godman B, et al. Among authors: haycox a. BMC Med. 2013 Aug 13;11:179. doi: 10.1186/1741-7015-11-179. BMC Med. 2013. PMID: 23941275 Free PMC article. Review.
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets.
Godman B, Bucsics A, Vella Bonanno P, Oortwijn W, Rothe CC, Ferrario A, Bosselli S, Hill A, Martin AP, Simoens S, Kurdi A, Gad M, Gulbinovič J, Timoney A, Bochenek T, Salem A, Hoxha I, Sauermann R, Massele A, Guerra AA Jr, Petrova G, Mitkova Z, Achniotou G, Laius O, Sermet C, Selke G, Kourafalos V, Yfantopoulos J, Magnusson E, Joppi R, Oluka M, Kwon HY, Jakupi A, Kalemeera F, Fadare JO, Melien O, Pomorski M, Wladysiuk M, Marković-Peković V, Mardare I, Meshkov D, Novakovic T, Fürst J, Tomek D, Zara C, Diogene E, Meyer JC, Malmström R, Wettermark B, Matsebula Z, Campbell S, Haycox A. Godman B, et al. Among authors: haycox a. Front Public Health. 2018 Dec 5;6:328. doi: 10.3389/fpubh.2018.00328. eCollection 2018. Front Public Health. 2018. PMID: 30568938 Free PMC article. Review.
Pharmacoeconomics: basic concepts and terminology.
Walley T, Haycox A. Walley T, et al. Among authors: haycox a. Br J Clin Pharmacol. 1997 Apr;43(4):343-8. doi: 10.1046/j.1365-2125.1997.00574.x. Br J Clin Pharmacol. 1997. PMID: 9146844 Free PMC article. Review. No abstract available.
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.
Adamski J, Godman B, Ofierska-Sujkowska G, Osińska B, Herholz H, Wendykowska K, Laius O, Jan S, Sermet C, Zara C, Kalaba M, Gustafsson R, Garuolienè K, Haycox A, Garattini S, Gustafsson LL. Adamski J, et al. Among authors: haycox a. BMC Health Serv Res. 2010 Jun 7;10:153. doi: 10.1186/1472-6963-10-153. BMC Health Serv Res. 2010. PMID: 20529296 Free PMC article. Review.
Accounting for noncompliance in pharmacoeconomic evaluations.
Hughes DA, Bagust A, Haycox A, Walley T. Hughes DA, et al. Among authors: haycox a. Pharmacoeconomics. 2001;19(12):1185-97. doi: 10.2165/00019053-200119120-00001. Pharmacoeconomics. 2001. PMID: 11772154 Review.
120 results